Eric Chin

Eric Chin (finance chief) discloses dealings in 2 companies, chiefly Astrana Health, Inc. and Biomerica Inc. In total, 4 filings cover trades dated from 3 February 2022 to 26 August 2026.

Purchases make up the whole of the open-market record (1 purchase, €8,566). Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 3 share grants. In 2026 alone, the filings show 1 purchase and no sales.

Most recently, on 27 August 2026, the filings show an open-market purchase worth €8,566 in Biomerica Inc. Typically, a trade is published a median of 4 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.